The_DT
normal_JJ
cell_NN
cycle_NN
activation_NN
program_NN
is_VBZ
exploited_VBN
during_IN
the_DT
infection_NN
of_IN
quiescent_JJ
B_NN
lymphocytes_NNS
by_IN
Epstein-Barr_JJ
virus_NN
._.

B_NN
lymphocytes_NNS
in_IN
the_DT
peripheral_JJ
circulation_NN
are_VBP
maintained_VBN
in_IN
a_DT
non-proliferative_JJ
state_NN
._.

Antigen_NN
recognition_NN
stimulates_VBZ
limited_JJ
proliferation_NN
,_,
whereas_IN
infection_NN
with_IN
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
results_VBZ
in_IN
continual_JJ
proliferation_NN
and_CC
the_DT
outgrowth_NN
of_IN
immortal_JJ
cell_NN
lines_NNS
._.

Because_IN
it_PRP
is_VBZ
not_RB
clear_JJ
at_IN
which_WDT
point_NN
in_IN
cell_NN
cycle_NN
the_DT
peripheral_JJ
B_NN
lymphocytes_NNS
are_VBP
arrested_VBN
,_,
we_PRP
characterized_VBD
the_DT
expression_NN
of_IN
several_JJ
cell_NN
cycle-associated_JJ
genes_NNS
in_IN
quiescent_JJ
and_CC
stimulated_JJ
cells_NNS
._.

We_PRP
show_VBP
that_IN
the_DT
expression_NN
of_IN
four_CD
cell_NN
genes_NNS
,_,
cdc-2_NN
,_,
cyclin_NN
E_NN
,_,
CD23_NN
,_,
and_CC
cyclin_NN
D2_NN
,_,
are_VBP
up-regulated_VBN
approximately_RB
100-fold_RB
as_IN
a_DT
result_NN
of_IN
EBV-mediated_JJ
immortalization_NN
._.

Because_IN
these_DT
genes_NNS
play_VBP
a_DT
positive_JJ
role_NN
in_IN
cell_NN
proliferation_NN
,_,
we_PRP
suggest_VBP
that_IN
this_DT
regulatory_JJ
switch_NN
contributes_VBZ
to_TO
controlling_VBG
entry_NN
into_IN
the_DT
cell_NN
cycle_NN
._.

Transient_JJ
stimulation_NN
of_IN
quiescent_JJ
B_NN
lymphocytes_NNS
with_IN
either_CC
a_DT
cocktail_NN
of_IN
anti-CD40_NN
,_,
anti-IgM_NN
,_,
and_CC
IL4_NN
,_,
or_CC
EBV_NN
results_VBZ
in_IN
the_DT
rapid_JJ
expression_NN
of_IN
the_DT
same_JJ
four_CD
genes_NNS
,_,
suggesting_VBG
that_IN
,_,
after_IN
infection_NN
,_,
EBV_NN
exploits_VBZ
the_DT
normal_JJ
program_NN
of_IN
B-lymphocyte_NN
cell_NN
cycle_NN
activation_NN
._.

